Suppr超能文献

肠促胰岛素受体配体识别的结构基础。

Structural basis for ligand recognition of incretin receptors.

机构信息

Department of Chemistry, MEMPHYS Center for Biomembrane Physics, Technical University of Denmark, Kgs. Lyngby, Denmark, GLP-1 and Obesity Biology, Novo Nordisk, Måløv, Denmark.

出版信息

Vitam Horm. 2010;84:251-78. doi: 10.1016/B978-0-12-381517-0.00009-6.

Abstract

The glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor are homologous G-protein-coupled receptors (GPCRs). Incretin receptor agonists stimulate the synthesis and secretion of insulin from pancreatic β-cells and are therefore promising agents for the treatment of type 2 diabetes. It is well established that the N-terminal extracellular domain (ECD) of incretin receptors is important for ligand binding and ligand specificity, whereas the transmembrane domain is involved in receptor activation. Structures of the ligand-bound ECD of incretin receptors have been solved recently by X-ray crystallography. The crystal structures reveal a similar fold of the ECD and a similar mechanism of ligand binding, where the ligand adopts an α-helical conformation. Residues in the C-terminal part of the ligand interact directly with the ECD and hydrophobic interactions appear to be the main driving force for ligand binding to the ECD of incretin receptors. Obviously, the-still missing-structures of full-length incretin receptors are required to construct a complete picture of receptor function at the molecular level. However, the progress made recently in structural analysis of the ECDs of incretin receptors and related GPCRs has shed new light on the process of ligand recognition and binding and provided a basis to disclose some of the mechanisms underlying receptor activation at high resolution.

摘要

葡萄糖依赖性胰岛素促分泌多肽 (GIP) 受体和胰高血糖素样肽-1 (GLP-1) 受体是同源的 G 蛋白偶联受体 (GPCR)。肠降血糖素受体激动剂刺激胰腺 β 细胞合成和分泌胰岛素,因此是治疗 2 型糖尿病的有前途的药物。已经证实,肠降血糖素受体的 N 端细胞外结构域 (ECD) 对于配体结合和配体特异性很重要,而跨膜结构域参与受体激活。最近通过 X 射线晶体学解决了配体结合的肠降血糖素受体 ECD 的结构。晶体结构揭示了 ECD 的相似折叠和配体结合的相似机制,其中配体采用 α-螺旋构象。配体 C 末端的残基与 ECD 直接相互作用,疏水力似乎是配体与肠降血糖素受体 ECD 结合的主要驱动力。显然,需要完整的全长肠降血糖素受体结构来构建受体功能的分子水平的完整图像。然而,最近对肠降血糖素受体和相关 GPCR 的 ECD 结构分析的进展揭示了配体识别和结合的过程,并为揭示受体激活的一些机制提供了基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验